Skip to content

Clinical Trial on the Safety and Efficacy of the Knee Prosthesis System for Total Knee Arthroplasty

Clinical Trial on the Safety and Efficacy of the Knee Prosthesis System for Total Knee Arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120085
Enrollment
Unknown
Registered
2026-03-09
Start date
2021-09-01
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

Biological Fixation Group:None
Cement Fixation Group:None

Sponsors

Red Cross Hospital Affiliated to Xi 'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged >50 and <80 years, regardless of sex. Younger patients were required to have a compelling clinical indication for surgery; 2. Patients with skeletal maturity; 3. The prosthesis was indicated for end-stage knee diseases, including osteoarthritis, post-traumatic arthritis, osteonecrosis, and inflammatory arthropathies (all diagnosed according to internationally recognized clinical, radiographic, and rheumatologic classification criteria), as well as deformity correction, reconstruction after failure of a partial knee prosthesis, and fractures not amenable to other treatment techniques requiring total knee arthroplasty; 4. The affected limb was undergoing primary total knee arthroplasty; 5. Prior to surgery, the participant or legal guardian was willing and able to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Neuromuscular dysfunction (e.g., paralysis, myolysis, or muscle weakness) that could lead to postoperative knee instability or abnormal gait; 2. Mental incapacity or inability to understand the requirements of study participation; 3. Alcoholism, drug addiction, or substance abuse; 4. Anticipated poor compliance; 5. Obesity (BMI > 35 kg/m^2); 6. Known hypersensitivity to one or more implant materials; 7. Active infection in the knee or elsewhere in the body; 8. Severe osteoporosis, metabolic bone disease, radiation-induced bone disease, or tumors around the knee; 9. Pregnant or breastfeeding women; 10. Frailty or inability to tolerate surgery due to other systemic diseases; 11. Comorbid conditions that could limit participation, impair follow-up compliance, or compromise the scientific integrity of the study; 12. Participation in other drug, biologic, or medical device clinical trials prior to enrollment without reaching the primary endpoint time frame; 13. Any other condition deemed by the investigator to make the patient unsuitable for participation.

Design outcomes

Primary

MeasureTime frame
Knee Society Score (KSS) Excellent and Good Rate;

Secondary

MeasureTime frame
Knee Society Score (KSS);Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Score;Prosthesis Survival Rate;Radiographic Parameters on X-ray Plain Films;

Countries

China

Contacts

Public ContactMa Jianbing

Red Cross Hospital Affiliated to Xi 'an Jiaotong University

13299028888@163.com+86 132 9902 8888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026